The study describes a clinically useful method for determining digoxin levels in human plasma using 86Rb transport inhibition, achieving a sensitivity of 0.3-0.5 mμg/mL.
Answers are grounded in this paper and cite their sources.
May enable digoxin monitoring at therapeutic levels; leaves open prospective validation before routine clinical adoption.
A clinically useful method for determination of digoxin in plasma is described. It is based on the ability of digitalis glycosides to inhibit the transport of 86Rb into erythrocytes. The different steps of the method are critically examined. The lower limit of sensitivity seems to be between 0.3 and 0.5 mμg of digoxin per milliliter of plasma. Some clinical findings are presented.
No takes yet. Share an insight, caveat, or question.
Åke Bertler (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: